Instinct Bio Technical Co. Holdings Inc. (BIOT) stock price, financials & research

Regular session · ET · Market data may be delayed.

Company profile

An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.

Industry: Household & Personal Products
Sector: Consumer Defensive
Headquarters: US
CEO: Tomoki Nagano
Listed since: Jul 24, 2026
Employees: 2

Market position

Day range

Current $0.3768

$0.356$0.3848

52-week range

Current $0.3768

$0.33$50.00

Open: $0.376
Previous close: $0.383
Volume: 212.42K; 0.29× average
Average volume: 722.88K; Average daily volume
Market cap: 1.62M USD
Beta: -0.54; Market reference 1
50-day average: $0.408; -7.65% below average
200-day average: $0.7542; -50.04% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): -0.9×
P/B (TTM): -398,715.5×
P/S (TTM): 0×
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 0.00%
Operating margin: 0.00%
Net margin: 0.00%

Financial health

Debt / equity: 0×

BIOT news

globenewswire.comSep 4, 2026

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

NEW YORK and TOKYO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.

Read source

globenewswire.comAug 10, 2026

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

NEW YORK and TOKYO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today announced a cooperation agreement with PT PARVA CANDELA ("PARVA"),…

Read source

globenewswire.comJul 29, 2026

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

NEW YORK and TOKYO, July 29, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ: BIOT) ("Instinct Bio" or the "Company") today announced its decision to bring its own Japanese aesthetic…

Read source

globenewswire.comJul 29, 2026

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” Building a Recurring-Revenue Platform

Read source

globenewswire.comJul 28, 2026

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

Transformative funding agreement equips Instinct Bio with discretionary capital to scale its longevity-focused ecosystem and capture market opportunities. Transformative funding agreement equips Instinct Bio with…

Read source

BIOT peers

WMT

Walmart Inc.

$110.24

+1.92%

COST

Costco Wholesale Corporation

$947.66

+0.57%

PEP

PepsiCo, Inc.

$125.15

+1.15%

MNST

Monster Beverage Corporation

$43.6968

+1.90%

MDLZ

Mondelez International, Inc.

$59.875

+0.83%

CCEP

Coca-Cola Europacific Partners PLC

$102.82

+1.95%

Instinct Bio Technical Co. Holdings Inc.

Company profile

Instinct Bio Technical Co. Holdings Inc.

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

BIOT news

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

BIOT peers

Continue in GoAI

Company profile

Market position

Company profile

Company profile

Market position

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

BIOT news

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

BIOT peers

Continue in GoAI

Instinct Bio Technical Co. Holdings Inc.

BIOT company overview

Company profile

Instinct Bio Technical Co. Holdings Inc.

BIOT company overview

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

BIOT news

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

BIOT peers

Continue in GoAI

BIOT company overview

Company profile

Market position

BIOT company overview

Company profile

BIOT company overview

Company profile

Market position

BIOT company overview

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

BIOT news

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

BIOT peers

Continue in GoAI